Drug Shortage Report for PRIORIX

Last updated on 2023-03-16 History
Report ID 185638
Drug Identification Number 02239208
Brand name PRIORIX
Common or Proper name Combined measles, mumps and rubella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) WATER RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED
Strength(s) 0.5ML 1000CCID50 1000CCID50 10000CCID50
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration SUBCUTANEOUS INTRAMUSCULAR INTRAMUSCULAR SUBCUTANEOUS
Packaging size 10s
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-22
Estimated end date 2023-03-17
Actual end date 2023-03-15
Shortage status Resolved
Updated date 2023-03-16
Company comments Limited supply available for public programs. Supply unavailable for the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-03-16 English Compare
v6 2023-03-15 French Compare
v5 2023-03-15 English Compare
v4 2023-03-10 French Compare
v3 2023-03-10 English Compare
v2 2023-02-27 French Compare
v1 2023-02-27 English Compare

Showing 1 to 7 of 7